Interventions for valvular disease Transcatheter aortic valve implantation after transcatheter mitral valve implantation Kuhn E, Rudolph V, Baldus S, Adam M November 20, 2019 | 10.4244/EIJ-D-19-00690
Interventions for valvular disease Acute kidney injury following percutaneous edge-to-edge vs. minimally invasive surgical mitral valve repair: incidence, predictors and prognostic value Körber M, Scherner M, Kuhr K, Kasisada H, Ney S, Pfister R, Rahmanian P, Wippermann J, Wahlers T, Baldus S, Rudolph V February 20, 2018 | 10.4244/EIJ-D-17-00131
Interventions for valvular disease Successful treatment of an iatrogenic membranous ventricular septal defect (IVSD) following Edwards SAPIEN 3 implantation by a valve-in-valve procedure Rudolph T, Scherner M, Kuhn E, Rudolph V, Mauri V, Rosenkranz S, Wahlers T, Baldus S, Mader N April 20, 2016 | 10.4244/EIJV11I13A300
Predictors of recurrent stroke after percutaneous closure of patent foramen ovale Rudolph V, Augustin J, Hofmann T, Hamm C, Meinertz T, Koster R, Baldus S, Franzen O April 22, 2014 | 10.4244/EIJV9I12A239
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years (The Trials book is supported by Biotronik) December 13, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019